Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
SN | London | GBP | Real-time | |
SNl | BATS Europe | GBP | Delayed | |
SNN | NYSE | USD | Real-time |
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Deepak S. Nath | 50 | 2022 | CEO & Director |
Rupert Christopher Soames | 64 | 2023 | Independent Non-Executive Chairman |
Simon Jonathan Lowth | 63 | 2024 | Independent Non-Executive Director |
Jeremy Kim Maiden | 63 | 2023 | Independent Non-Executive Director |
John Terence Rogers | 55 | 2024 | CFO & Executive Director |
Joanna Christine Hallas | 54 | 2022 | Independent Non-Executive Director |
Katarzyna Mazur-Hofsaess | 61 | 2020 | Independent Non-Executive Director |
Changzheng Ma | 62 | 2021 | Independent Non-Executive Director |
Robert John White | 62 | 2020 | Independent Non-Executive Director |
Marc Ellis Owen | 65 | 2017 | Independent Director |
Angela Susan Risley | 66 | 2017 | Senior Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review